Improving fatigue and quality of life in older men with cancer and low testosterone
Official title: Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
Funded at Seattle Inst for Biomedical/clinical Res · NIH-10861052 · Data updated 2026-11-12
This study is looking at how testosterone replacement therapy might help older men with cancer feel less tired, improve their sex life, and boost their overall quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Inst for Biomedical/clinical Res NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 1, 2019 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $661,925 |
| NIH project number | 5R01AG061558-05 |
| Project ID | NIH-10861052 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older men aged 65 and above who are diagnosed with cancer and experiencing symptoms of fatigue and sexual dysfunction.
✕Less likely to help
Patients who are younger than 65 or those without cancer or testosterone deficiency may not benefit from this research.
What this research studies
This research investigates how testosterone replacement therapy can alleviate cancer-related fatigue, sexual dysfunction, and improve overall quality of life in older men diagnosed with cancer. The study aims to assess the effectiveness of this therapy, particularly in patients experiencing significant fatigue, which is common among those undergoing cancer treatments. By focusing on older men, the research seeks to address a critical gap in treatment options for this demographic, as current FDA-approved solutions for cancer-related fatigue are lacking. Participants will be monitored for improvements in their physical function and well-being throughout the study.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option that significantly enhances the quality of life for older men suffering from cancer-related fatigue and associated symptoms.
How similar studies have gone: Previous clinical trials have shown success in using testosterone replacement therapy for improving quality of life in non-cancer older men, but this specific application for cancer-related fatigue is novel.
Where this research is happening
-
Seattle Inst for Biomedical/clinical Res
Seattle, United States Active
Researchers
- Principal investigator: Garcia, Jose M. — Seattle Inst for Biomedical/clinical Res
- Study coordinator: Garcia, Jose M.
Related research
Other NIH-funded projects on the same topics.
-
Telehealth exercise program to help rural breast cancer survivors fight fatigue
A telehealth exercise program is being tested to reduce cancer-related fatigue in rural breast cancer survivors.
-
DESCANSO: A friendly CBT plan to ease depression, sleep problems, and fatigue in Latino cancer patients
A Spanish-speaking CBT program called DESCANSO is being tested to help Latino cancer patients feel less tired, sleep better, and happier.
-
Time-restricted eating for fatigue and frailty in people with cancer
A 12-week study will test whether eating within a daily 10-hour window helps reduce fatigue and slow frailty in people living with advanced cancer.
-
Gut microbiome imbalance linked to brain fog and fatigue after COVID-19
A study will explore whether shifts in gut bacteria after COVID-19 contribute to brain fog and fatigue and how this relationship could point to new treatments.
-
Standardized, patient-centered treatment plans for breast and gynecologic cancer survivors facing sexual dysfunction and vaginal microbiome changes
A patient-friendly program tests personalized, non-hormonal treatment plans for sexual dysfunction in breast cancer survivors, guided by changes in the vaginal microbiome.
-
Human Herpesvirus 6B and ME/CFS: does the virus cause or follow immune problems?
A study to see if HHV-6B reactivation is a cause or result of immune problems in people with ME/CFS, using long-term follow-up and biosamples from patients and controls.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.